Open-label Extension Study of Brazikumab in Ulcerative Colitis
Clinical trial NCT04277546 · TERMINATED
Trial details
- NCT number
- NCT04277546
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2023-10-10
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.